{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:23:22Z","timestamp":1779927802941,"version":"3.53.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12035-018-0959-2","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:57:01Z","timestamp":1522796221000},"page":"8455-8472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice"],"prefix":"10.1007","volume":"55","author":[{"given":"Rosalia","family":"Crupi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Casili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-3690","authenticated-orcid":false,"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"key":"959_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2015.11.008","volume":"41","author":"YI Lee","year":"2016","unstructured":"Lee YI, Kang H, Ha YW, Chang KY, Cho SC, Song SO, Kim H, Jo A et al (2016) Diaminodiphenyl sulfone-induced parkin ameliorates age-dependent dopaminergic neuronal loss. Neurobiol Aging 41:1\u201310. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.008","journal-title":"Neurobiol Aging"},{"key":"959_CR2","unstructured":"Cascianelli S, Tranfaglia C, Fravolini ML, Bianconi F, Minestrini M, Nuvoli S, Tambasco N, Dottorini ME, Palumbo B (2017) Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using (123)I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT). Hell J Nucl Med 20 Suppl:165"},{"key":"959_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","volume":"115","author":"V Calabrese","year":"2018","unstructured":"Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, Cuzzocrea S, Zappia M et al (2018) Aging and Parkinson's disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 115:80\u201391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.10.379","journal-title":"Free Radic Biol Med"},{"key":"959_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.exger.2017.10.023","volume":"100","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Eftekhari SM, Jamali-Raeufy N, Haghani S, Zeinali H, Roghani M (2017) The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA\/CaMKII\/CREB signaling. Exp Gerontol 100:70\u201376. https:\/\/doi.org\/10.1016\/j.exger.2017.10.023","journal-title":"Exp Gerontol"},{"key":"959_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"CW Olanow","year":"1999","unstructured":"Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123\u2013144. https:\/\/doi.org\/10.1146\/annurev.neuro.22.1.123","journal-title":"Annu Rev Neurosci"},{"issue":"Suppl 1","key":"959_CR6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1007\/s00115-003-1482-9","volume":"74","author":"G Becker","year":"2003","unstructured":"Becker G (2003) Methods for the early diagnosis of Parkinson's disease. Nervenarzt 74(Suppl 1):S7\u201311. https:\/\/doi.org\/10.1007\/s00115-003-1482-9","journal-title":"Nervenarzt"},{"issue":"3","key":"959_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/acel.12312","volume":"14","author":"M Rodriguez","year":"2015","unstructured":"Rodriguez M, Rodriguez-Sabate C, Morales I, Sanchez A, Sabate M (2015) Parkinson's disease as a result of aging. Aging Cell 14(3):293\u2013308. https:\/\/doi.org\/10.1111\/acel.12312","journal-title":"Aging Cell"},{"issue":"28","key":"959_CR8","doi-asserted-by":"publisher","first-page":"9310","DOI":"10.1523\/JNEUROSCI.4228-13.2014","volume":"34","author":"SY Branch","year":"2014","unstructured":"Branch SY, Sharma R, Beckstead MJ (2014) Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 34(28):9310\u20139318. https:\/\/doi.org\/10.1523\/JNEUROSCI.4228-13.2014","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"2","key":"959_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","volume":"205","author":"E Esposito","year":"2007","unstructured":"Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G (2007) Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp Neurol 205(2):295\u2013312. https:\/\/doi.org\/10.1016\/j.expneurol.2007.02.008","journal-title":"Exp Neurol"},{"issue":"1","key":"959_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00441-004-0954-y","volume":"318","author":"JB Schulz","year":"2004","unstructured":"Schulz JB, Falkenburger BH (2004) Neuronal pathology in Parkinson's disease. Cell Tissue Res 318(1):135\u2013147. https:\/\/doi.org\/10.1007\/s00441-004-0954-y","journal-title":"Cell Tissue Res"},{"issue":"12","key":"959_CR11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM et al (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5(12):1403\u20131409. https:\/\/doi.org\/10.1038\/70978","journal-title":"Nat Med"},{"key":"959_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuroscience.2017.11.041","volume":"369","author":"D Huang","year":"2018","unstructured":"Huang D, Wang Z, Tong J, Wang M, Wang J, Xu J, Bai X, Li H et al (2018) Long-term changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson's disease. Neuroscience 369:303\u2013313. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.11.041","journal-title":"Neuroscience"},{"issue":"3","key":"959_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","volume":"39","author":"M Kohutnicka","year":"1998","unstructured":"Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A (1998) Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39(3):167\u2013180","journal-title":"Immunopharmacology"},{"key":"959_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep15720","volume":"5","author":"J Liu","year":"2015","unstructured":"Liu J, Huang D, Xu J, Tong J, Wang Z, Huang L, Yang Y, Bai X et al (2015) Tiagabine protects dopaminergic neurons against neurotoxins by inhibiting microglial activation. Sci Rep 5:15720. https:\/\/doi.org\/10.1038\/srep15720","journal-title":"Sci Rep"},{"issue":"11","key":"959_CR15","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1093\/carcin\/15.11.2669","volume":"15","author":"K Shimoi","year":"1994","unstructured":"Shimoi K, Masuda S, Furugori M, Esaki S, Kinae N (1994) Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis 15(11):2669\u20132672","journal-title":"Carcinogenesis"},{"issue":"7","key":"959_CR16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8(7):634\u2013646","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"959_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/0929867023370707","volume":"9","author":"DM Lambert","year":"2002","unstructured":"Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9(6):663\u2013674","journal-title":"Curr Med Chem"},{"issue":"1","key":"959_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2010.03.022","volume":"224","author":"HS Hansen","year":"2010","unstructured":"Hansen HS (2010) Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp Neurol 224(1):48\u201355. https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.022","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"959_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2826.2008.01674.x","volume":"20","author":"D Filippis De","year":"2008","unstructured":"De Filippis D, D'Amico A, Iuvone T (2008) Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 20(Suppl 1):20\u201325. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01674.x","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"959_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12640-010-9166-2","volume":"19","author":"M Koch","year":"2011","unstructured":"Koch M, Kreutz S, Bottger C, Benz A, Maronde E, Ghadban C, Korf HW, Dehghani F (2011) Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-alpha. Neurotox Res 19(2):330\u2013340. https:\/\/doi.org\/10.1007\/s12640-010-9166-2","journal-title":"Neurotox Res"},{"issue":"1","key":"959_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pain.2011.08.010","volume":"153","author":"O Sasso","year":"2012","unstructured":"Sasso O, Russo R, Vitiello S, Raso GM, D'Agostino G, Iacono A, Rana GL, Vallee M et al (2012) Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain. Pain 153(1):33\u201341. https:\/\/doi.org\/10.1016\/j.pain.2011.08.010","journal-title":"Pain"},{"issue":"8","key":"959_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041880","volume":"7","author":"E Esposito","year":"2012","unstructured":"Esposito E, Impellizzeri D, Mazzon E, Paterniti I, Cuzzocrea S (2012) Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease. PLoS One 7(8):e41880. https:\/\/doi.org\/10.1371\/journal.pone.0041880","journal-title":"PLoS One"},{"issue":"6","key":"959_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbi.2011.02.006","volume":"25","author":"E Esposito","year":"2011","unstructured":"Esposito E, Paterniti I, Mazzon E, Genovese T, Di Paola R, Galuppo M, Cuzzocrea S (2011) Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav Immun 25(6):1099\u20131112. https:\/\/doi.org\/10.1016\/j.bbi.2011.02.006","journal-title":"Brain Behav Immun"},{"issue":"1","key":"959_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/jpet.108.136903","volume":"326","author":"T Genovese","year":"2008","unstructured":"Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A et al (2008) Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 326(1):12\u201323. https:\/\/doi.org\/10.1124\/jpet.108.136903","journal-title":"J Pharmacol Exp Ther"},{"key":"959_CR25","doi-asserted-by":"publisher","first-page":"138471","DOI":"10.4061\/2011\/138471","volume":"2011","author":"E Antzoulatos","year":"2011","unstructured":"Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI (2011) MPTP neurotoxicity and testosterone induce dendritic remodeling of striatal medium spiny neurons in the C57Bl\/6 mouse. Parkinson's disease 2011:138471\u2013138410. https:\/\/doi.org\/10.4061\/2011\/138471","journal-title":"Parkinson's disease"},{"issue":"42","key":"959_CR26","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. The Journal of neuroscience : the official journal of the Society for Neuroscience 24(42):9434\u20139440. https:\/\/doi.org\/10.1523\/JNEUROSCI.3080-04.2004","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"8","key":"959_CR27","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","volume":"25","author":"DY Hwang","year":"2005","unstructured":"Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS (2005) 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 25(8):2132\u20132137. https:\/\/doi.org\/10.1523\/JNEUROSCI.3718-04.2005","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"3","key":"959_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14(3):149\u2013167","journal-title":"J Neurosci Methods"},{"key":"959_CR29","doi-asserted-by":"crossref","unstructured":"Siracusa R, Paterniti I, Impellizzeri D, Cordaro M, Crupi R, Navarra M, Cuzzocrea S, Esposito E The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model. CNS Neurol Disord Drug Targets 14 (10):1350\u20131365. doi:CNSNDDT-EPUB-69743 [pii]","DOI":"10.2174\/1871527314666150821102823"},{"issue":"3","key":"959_CR30","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","volume":"55","author":"Rosalba Siracusa","year":"2017","unstructured":"Siracusa R, Paterniti I, Cordaro M, Crupi R, Bruschetta G, Campolo M, Cuzzocrea S, Esposito E (2017) Neuroprotective effects of Temsirolimus in animal models of Parkinson's disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0496-4","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"959_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029935","volume":"7","author":"KW Lee","year":"2012","unstructured":"Lee KW, Zhao X, Im JY, Grosso H, Jang WH, Chan TW, Sonsalla PK, German DC et al (2012) Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation. PLoS One 7(1):e29935. https:\/\/doi.org\/10.1371\/journal.pone.0029935","journal-title":"PLoS One"},{"key":"959_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00233","volume":"8","author":"R Siracusa","year":"2017","unstructured":"Siracusa R, Impellizzeri D, Cordaro M, Crupi R, Esposito E, Petrosino S, Cuzzocrea S (2017) Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia. Front Neurol 8:233. https:\/\/doi.org\/10.3389\/fneur.2017.00233","journal-title":"Front Neurol"},{"issue":"4","key":"959_CR33","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s12035-016-9827-0","volume":"54","author":"M Cordaro","year":"2017","unstructured":"Cordaro M, Paterniti I, Siracusa R, Impellizzeri D, Esposito E, Cuzzocrea S (2017) KU0063794, a dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice. Mol Neurobiol 54(4):2415\u20132427. https:\/\/doi.org\/10.1007\/s12035-016-9827-0","journal-title":"Mol Neurobiol"},{"key":"959_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1196\/annals.1354.010","volume":"1067","author":"L Demetrius","year":"2006","unstructured":"Demetrius L (2006) Aging in mouse and human systems: a comparative study. Ann N Y Acad Sci 1067:66\u201382. https:\/\/doi.org\/10.1196\/annals.1354.010","journal-title":"Ann N Y Acad Sci"},{"key":"959_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta S, Sengupta P (2016) Men and mice: relating their ages. Life Sci 152:244\u2013248. https:\/\/doi.org\/10.1016\/j.lfs.2015.10.025","journal-title":"Life Sci"},{"issue":"11","key":"959_CR36","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/ene.13106","volume":"23","author":"R Erro","year":"2016","unstructured":"Erro R, Picillo M, Vitale C, Amboni M, Moccia M, Santangelo G, Pellecchia MT, Barone P (2016) The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study. Eur J Neurol 23(11):1673\u20131679. https:\/\/doi.org\/10.1111\/ene.13106","journal-title":"Eur J Neurol"},{"issue":"Pt 9","key":"959_CR37","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awu193","volume":"137","author":"H Hall","year":"2014","unstructured":"Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, Thompson L, Halliday G et al (2014) Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain : a journal of neurology 137(Pt 9):2493\u20132508. https:\/\/doi.org\/10.1093\/brain\/awu193","journal-title":"Brain : a journal of neurology"},{"issue":"2","key":"959_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.26112","volume":"30","author":"TJ Mierlo van","year":"2015","unstructured":"van Mierlo TJ, Chung C, Foncke EM, Berendse HW, van den Heuvel OA (2015) Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume. Movement disorders: official journal of the Movement Disorder Society 30(2):245\u2013252. https:\/\/doi.org\/10.1002\/mds.26112","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"2","key":"959_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57(2):168\u2013175. https:\/\/doi.org\/10.1002\/ana.20338","journal-title":"Ann Neurol"},{"issue":"29","key":"959_CR40","doi-asserted-by":"publisher","first-page":"3re","DOI":"10.1126\/sageke.2002.29.re3","volume":"2002","author":"P. L. McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG (2002) Innate immunity, local inflammation, and degenerative disease. Science of aging knowledge environment : SAGE KE 2002 (29):re3. https:\/\/doi.org\/10.1126\/sageke.2002.29.re3","journal-title":"Science of Aging Knowledge Environment"},{"issue":"2","key":"959_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol 193(2):279\u2013290. https:\/\/doi.org\/10.1016\/j.expneurol.2005.01.013","journal-title":"Exp Neurol"},{"issue":"10","key":"959_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tips.2005.08.007","volume":"26","author":"B Marchetti","year":"2005","unstructured":"Marchetti B, Abbracchio MP (2005) To be or not to be (inflamed)\u2014is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Sci 26(10):517\u2013525. https:\/\/doi.org\/10.1016\/j.tips.2005.08.007","journal-title":"Trends Pharmacol Sci"},{"issue":"2\u20133","key":"959_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","volume":"419","author":"A Calignano","year":"2001","unstructured":"Calignano A, La Rana G, Piomelli D (2001) Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 419(2\u20133):191\u2013198","journal-title":"Eur J Pharmacol"},{"key":"959_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001922.pub3","volume":"8","author":"M Naccarato","year":"2010","unstructured":"Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA (2010) Physical methods for preventing deep vein thrombosis in stroke. The Cochrane database of systematic reviews 8:CD001922. https:\/\/doi.org\/10.1002\/14651858.CD001922.pub3","journal-title":"The Cochrane database of systematic reviews"},{"issue":"7","key":"959_CR45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2174\/18715273113129990084","volume":"12","author":"R Crupi","year":"2013","unstructured":"Crupi R, Paterniti I, Ahmad A, Campolo M, Esposito E, Cuzzocrea S (2013) Effects of palmitoylethanolamide and luteolin in an animal model of anxiety\/depression. CNS & neurological disorders drug targets 12(7):989\u20131001","journal-title":"CNS & neurological disorders drug targets"},{"issue":"1","key":"959_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000445628","volume":"39","author":"S Palee","year":"2016","unstructured":"Palee S, Apaijai N, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N (2016) Acetylcholine attenuates hydrogen peroxide-induced intracellular calcium dyshomeostasis through both muscarinic and nicotinic receptors in cardiomyocytes. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 39(1):341\u2013349. https:\/\/doi.org\/10.1159\/000445628","journal-title":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"issue":"1","key":"959_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cns.12648","volume":"23","author":"B Bertolino","year":"2017","unstructured":"Bertolino B, Crupi R, Impellizzeri D, Bruschetta G, Cordaro M, Siracusa R, Esposito E, Cuzzocrea S (2017) Beneficial effects of co-ultramicronized palmitoylethanolamide\/luteolin in a mouse model of autism and in a case report of autism. CNS neuroscience & therapeutics 23(1):87\u201398. https:\/\/doi.org\/10.1111\/cns.12648","journal-title":"CNS neuroscience & therapeutics"},{"key":"959_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2016.03.016","volume":"65","author":"T Asakawa","year":"2016","unstructured":"Asakawa T, Fang H, Sugiyama K, Nozaki T, Hong Z, Yang Y, Hua F, Ding G et al (2016) Animal behavioral assessments in current research of Parkinson's disease. Neurosci Biobehav Rev 65:63\u201394. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.03.016","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"959_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM et al (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1):239\u2013252","journal-title":"Neuron"},{"issue":"1","key":"959_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA et al (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65(1):66\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2009.12.023","journal-title":"Neuron"},{"issue":"30","key":"959_CR51","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott D, Roy S (2012) Alpha-synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. The Journal of neuroscience : the official journal of the Society for Neuroscience 32(30):10129\u201310135. https:\/\/doi.org\/10.1523\/JNEUROSCI.0535-12.2012","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"2","key":"959_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0306-4522(93)90335-D","volume":"56","author":"HA Cameron","year":"1993","unstructured":"Cameron HA, Woolley CS, McEwen BS, Gould E (1993) Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience 56(2):337\u2013344","journal-title":"Neuroscience"},{"issue":"8","key":"959_CR53","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nn.2156","volume":"11","author":"N Toni","year":"2008","unstructured":"Toni N, Laplagne DA, Zhao C, Lombardi G, Ribak CE, Gage FH, Schinder AF (2008) Neurons born in the adult dentate gyrus form functional synapses with target cells. Nat Neurosci 11(8):901\u2013907. https:\/\/doi.org\/10.1038\/nn.2156","journal-title":"Nat Neurosci"},{"issue":"Suppl 8","key":"959_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1528-1167.2007.01355.x","volume":"48","author":"JM Parent","year":"2007","unstructured":"Parent JM, Jessberger S, Gage FH, Gong C (2007) Is neurogenesis reparative after status epilepticus? Epilepsia 48(Suppl 8):69\u201371","journal-title":"Epilepsia"},{"issue":"2","key":"959_CR55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"key":"959_CR56","first-page":"193","volume":"55","author":"RJ Mayer","year":"1989","unstructured":"Mayer RJ, Lowe J, Lennox G, Landon M, MacLennan K, Doherty FJ (1989) Intermediate filament-ubiquitin diseases: implications for cell sanitization. Biochem Soc Symp 55:193\u2013201","journal-title":"Biochem Soc Symp"},{"issue":"4","key":"959_CR57","first-page":"809","volume":"140","author":"PG Galloway","year":"1992","unstructured":"Galloway PG, Mulvihill P, Perry G (1992) Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 140(4):809\u2013822","journal-title":"Am J Pathol"},{"issue":"4587","key":"959_CR58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"Suppl 1","key":"959_CR59","first-page":"35","volume":"13","author":"S Przedborski","year":"1998","unstructured":"Przedborski S, Jackson-Lewis V (1998) Mechanisms of MPTP toxicity. Movement disorders: official journal of the Movement Disorder Society 13(Suppl 1):35\u201338","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"12","key":"959_CR60","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3(12):1301\u20131306. https:\/\/doi.org\/10.1038\/81834","journal-title":"Nat Neurosci"},{"issue":"10","key":"959_CR61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1006\/cbir.2001.0772","volume":"25","author":"G Cappelletti","year":"2001","unstructured":"Cappelletti G, Pedrotti B, Maggioni MG, Maci R (2001) Microtubule assembly is directly affected by MPP(+)in vitro. Cell Biol Int 25(10):981\u2013984. https:\/\/doi.org\/10.1006\/cbir.2001.0772","journal-title":"Cell Biol Int"},{"key":"959_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep01837","volume":"3","author":"D Cartelli","year":"2013","unstructured":"Cartelli D, Casagrande F, Busceti CL, Bucci D, Molinaro G, Traficante A, Passarella D, Giavini E et al (2013) Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. Sci Rep 3:1837. https:\/\/doi.org\/10.1038\/srep01837","journal-title":"Sci Rep"},{"issue":"3","key":"959_CR63","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1128\/MCB.9.3.1049","volume":"9","author":"D Burke","year":"1989","unstructured":"Burke D, Gasdaska P, Hartwell L (1989) Dominant effects of tubulin overexpression in Saccharomyces cerevisiae. Mol Cell Biol 9(3):1049\u20131059","journal-title":"Mol Cell Biol"},{"issue":"10","key":"959_CR64","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1128\/MCB.10.10.5295","volume":"10","author":"B Weinstein","year":"1990","unstructured":"Weinstein B, Solomon F (1990) Phenotypic consequences of tubulin overproduction in Saccharomyces cerevisiae: differences between alpha-tubulin and beta-tubulin. Mol Cell Biol 10(10):5295\u20135304","journal-title":"Mol Cell Biol"},{"issue":"4","key":"959_CR65","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(09)70062-6","journal-title":"Lancet Neurol"},{"issue":"2","key":"959_CR66","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2008.04.008","volume":"212","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Exp Neurol 212(2):235\u2013238. https:\/\/doi.org\/10.1016\/j.expneurol.2008.04.008","journal-title":"Exp Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0959-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0959-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0959-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T21:33:20Z","timestamp":1571002400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0959-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0959-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,19]]},"assertion":[{"value":"15 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Salvatore Cuzzocrea is co-inventor on patent WO2013121449 A8 (Epitech Group Srl) which deals with methods and compositions for the modulation of amidases capable of hydrolysingN-acylethanolamines employable in the treatment of inflammatory diseases. This invention is wholly unrelated to the present study. Moreover, Prof. Cuzzocrea is also, with Epitech Group, a co-inventor on the following patent: EP 2821083; MI2014 A001495; 102015000067344 that are however unrelated to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure Statement"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}